Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.

Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG; S-CitAD Research Group.

Alzheimers Dement. 2019 Nov;15(11):1427-1436. doi: 10.1016/j.jalz.2019.06.4946. Epub 2019 Oct 3.

PMID:
31587995
2.

Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease.

Wang Z, Molsberry SA, Cheng Y, Kingsley L, Levine AJ, Martin E, Munro CA, Ragin A, Rubin LH, Sacktor N, Seaberg EC, Becker JT; Neuropsychology Working Group of the Multicenter AIDS Cohort Study.

AIDS. 2019 Nov 15;33(14):2115-2124. doi: 10.1097/QAD.0000000000002312.

PMID:
31335803
3.

An ex vivo Human Skin Model to Study Superficial Fungal Infections.

Corzo-León DE, Munro CA, MacCallum DM.

Front Microbiol. 2019 Jun 5;10:1172. doi: 10.3389/fmicb.2019.01172. eCollection 2019.

4.

Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study.

Rubin LH, Gustafson D, Hawkins KL, Zhang L, Jacobson LP, Becker JT, Munro CA, Lake JE, Martin E, Levine A, Brown TT, Sacktor N, Erlandson KM.

Neurology. 2019 Jul 16;93(3):e261-e271. doi: 10.1212/WNL.0000000000007779. Epub 2019 Jun 14. Erratum in: Neurology. 2019 Sep 3;93(10):465.

PMID:
31201294
5.

The potential of respiration inhibition as a new approach to combat human fungal pathogens.

Duvenage L, Munro CA, Gourlay CW.

Curr Genet. 2019 Dec;65(6):1347-1353. doi: 10.1007/s00294-019-01001-w. Epub 2019 Jun 6. Review.

6.

Stressful life events and cognitive decline: Sex differences in the Baltimore Epidemiologic Catchment Area Follow-Up Study.

Munro CA, Wennberg AM, Bienko N, Eaton WW, Lyketsos CG, Spira AP.

Int J Geriatr Psychiatry. 2019 Jul;34(7):1008-1017. doi: 10.1002/gps.5102. Epub 2019 Apr 25.

PMID:
30901482
7.

Changes in cognition precede changes in HRQoL among HIV+ males: Longitudinal analysis of the multicenter AIDS cohort study.

Jones JD, Kuhn T, Levine A, Sacktor N, Munro CA, Teplin LA, D'Souza G, Martin EM, Becker JT, Miller EN, Hinkin CH.

Neuropsychology. 2019 Mar;33(3):370-378. doi: 10.1037/neu0000530.

PMID:
30816783
8.

Inhibition of Classical and Alternative Modes of Respiration in Candida albicans Leads to Cell Wall Remodeling and Increased Macrophage Recognition.

Duvenage L, Walker LA, Bojarczuk A, Johnston SA, MacCallum DM, Munro CA, Gourlay CW.

MBio. 2019 Jan 29;10(1). pii: e02535-18. doi: 10.1128/mBio.02535-18.

9.

Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease.

Popov M, Molsberry SA, Lecci F, Junker B, Kingsley LA, Levine A, Martin E, Miller E, Munro CA, Ragin A, Seaberg E, Sacktor N, Becker JT.

Brain Imaging Behav. 2019 Jan 9. doi: 10.1007/s11682-018-0026-7. [Epub ahead of print]

PMID:
30623289
10.

The concept of mild cognitive impairment: a victim of its ubiquity.

Munro CA.

Int Psychogeriatr. 2018 Oct;30(10):1423-1425. doi: 10.1017/S1041610218001850.

PMID:
30426915
11.

Hypoxia Promotes Immune Evasion by Triggering β-Glucan Masking on the Candida albicans Cell Surface via Mitochondrial and cAMP-Protein Kinase A Signaling.

Pradhan A, Avelar GM, Bain JM, Childers DS, Larcombe DE, Netea MG, Shekhova E, Munro CA, Brown GD, Erwig LP, Gow NAR, Brown AJP.

MBio. 2018 Nov 6;9(6). pii: e01318-18. doi: 10.1128/mBio.01318-18.

12.

A High-Throughput Candida albicans Two-Hybrid System.

Schoeters F, Munro CA, d'Enfert C, Van Dijck P.

mSphere. 2018 Aug 22;3(4). pii: e00391-18. doi: 10.1128/mSphere.00391-18.

13.

Intraindividual variability in neurocognitive performance: No influence due to HIV status or self-reported effort.

Levine AJ, Martin E, Munro CA, Sacktor N, Horvath S, Becker JT; Multicenter AIDS Cohort Study–Neuropsychology Working Group.

J Clin Exp Neuropsychol. 2018 Dec;40(10):1044-1049. doi: 10.1080/13803395.2018.1508554. Epub 2018 Aug 20.

14.

Erratum: Generating genomic platforms to study Candida albicans pathogenesis.

Legrand M, Bachellier-Bassi S, Lee KK, Chaudhari Y, Tournu H, Arbogast L, Boyer H, Chauvel M, Cabral V, Maufrais C, Nesseir A, Maslanka I, Permal E, Rossignol T, Walker LA, Zeidler U, Znaidi S, Schoeters F, Majgier C, Julien RA, Ma L, Tichit M, Bouchier C, Van Dijck P, Munro CA, d'Enfert C.

Nucleic Acids Res. 2018 Sep 19;46(16):8664. doi: 10.1093/nar/gky747. No abstract available.

15.

Systematic gene overexpression in Candida albicans identifies a regulator of early adaptation to the mammalian gut.

Znaidi S, van Wijlick L, Hernández-Cervantes A, Sertour N, Desseyn JL, Vincent F, Atanassova R, Gouyer V, Munro CA, Bachellier-Bassi S, Dalle F, Jouault T, Bougnoux ME, d'Enfert C.

Cell Microbiol. 2018 Nov;20(11):e12890. doi: 10.1111/cmi.12890. Epub 2018 Aug 7.

16.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

17.

Generating genomic platforms to study Candida albicans pathogenesis.

Legrand M, Bachellier-Bassi S, Lee KK, Chaudhari Y, Tournu H, Arbogast L, Boyer H, Chauvel M, Cabral V, Maufrais C, Nesseir A, Maslanka I, Permal E, Rossignol T, Walker LA, Zeidler U, Znaidi S, Schoeters F, Majgier C, Julien RA, Ma L, Tichit M, Bouchier C, Van Dijck P, Munro CA, d'Enfert C.

Nucleic Acids Res. 2018 Aug 21;46(14):6935-6949. doi: 10.1093/nar/gky594. Erratum in: Nucleic Acids Res. 2018 Sep 19;46(16):8664.

18.

Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease.

Tao Y, Peters ME, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Munro CA.

Am J Alzheimers Dis Other Demen. 2018 Nov;33(7):450-457. doi: 10.1177/1533317518783278. Epub 2018 Jul 3.

19.

Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.

Leoutsakos JS, Yan H, Anderson WS, Asaad WF, Baltuch G, Burke A, Chakravarty MM, Drake KE, Foote KD, Fosdick L, Giacobbe P, Mari Z, McAndrews MP, Munro CA, Oh ES, Okun MS, Pendergrass JC, Ponce FA, Rosenberg PB, Sabbagh MN, Salloway S, Tang-Wai DF, Targum SD, Wolk D, Lozano AM, Smith GS, Lyketsos CG.

J Alzheimers Dis. 2018;64(2):597-606. doi: 10.3233/JAD-180121.

20.

HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.

Wu M, Fatukasi O, Yang S, Alger J, Barker PB, Hetherington H, Kim T, Levine A, Martin E, Munro CA, Parrish T, Ragin A, Sacktor N, Seaberg E, Becker JT; Neuropsychology Working Group of the Multicenter AIDS Cohort Study.

AIDS. 2018 Aug 24;32(13):1803-1810. doi: 10.1097/QAD.0000000000001891.

21.

Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.

Molsberry SA, Cheng Y, Kingsley L, Jacobson L, Levine AJ, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N, Becker JT; Neuropsychology Working Group of the Multicenter AIDS Cohort Study.

AIDS. 2018 Jul 31;32(12):1679-1688. doi: 10.1097/QAD.0000000000001865.

22.

Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection.

Yang J, Jacobson LP, Becker JT, Levine A, Martin EM, Munro CA, Palella FJ, Lake JE, Sacktor NC, Brown TT.

AIDS. 2018 Aug 24;32(13):1849-1860. doi: 10.1097/QAD.0000000000001842. Erratum in: AIDS. 2019 Mar 15;33(4):767.

23.

Cell walls of the dimorphic fungal pathogens Sporothrix schenckii and Sporothrix brasiliensis exhibit bilaminate structures and sloughing of extensive and intact layers.

Lopes-Bezerra LM, Walker LA, Niño-Vega G, Mora-Montes HM, Neves GWP, Villalobos-Duno H, Barreto L, Garcia K, Franco B, Martínez-Álvarez JA, Munro CA, Gow NAR.

PLoS Negl Trop Dis. 2018 Mar 9;12(3):e0006169. doi: 10.1371/journal.pntd.0006169. eCollection 2018 Mar.

24.

Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".

Mercer DK, Katvars LK, Hewitt F, Smith DW, Robertson J, Munro CA, O'Neil DA.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e00114-18. doi: 10.1128/AAC.00114-18. Print 2018 Mar. No abstract available.

25.

Sfp1 and Rtg3 reciprocally modulate carbon source-conditional stress adaptation in the pathogenic yeast Candida albicans.

Kastora SL, Herrero-de-Dios C, Avelar GM, Munro CA, Brown AJP.

Mol Microbiol. 2017 Aug;105(4):620-636. doi: 10.1111/mmi.13722. Epub 2017 Jun 19.

26.

Elevated catalase expression in a fungal pathogen is a double-edged sword of iron.

Pradhan A, Herrero-de-Dios C, Belmonte R, Budge S, Lopez Garcia A, Kolmogorova A, Lee KK, Martin BD, Ribeiro A, Bebes A, Yuecel R, Gow NAR, Munro CA, MacCallum DM, Quinn J, Brown AJP.

PLoS Pathog. 2017 May 22;13(5):e1006405. doi: 10.1371/journal.ppat.1006405. eCollection 2017 May.

27.

The Fungal Cell Wall: Structure, Biosynthesis, and Function.

Gow NAR, Latge JP, Munro CA.

Microbiol Spectr. 2017 May;5(3). doi: 10.1128/microbiolspec.FUNK-0035-2016. Review.

PMID:
28513415
28.

Molecular imaging of serotonin degeneration in mild cognitive impairment.

Smith GS, Barrett FS, Joo JH, Nassery N, Savonenko A, Sodums DJ, Marano CM, Munro CA, Brandt J, Kraut MA, Zhou Y, Wong DF, Workman CI.

Neurobiol Dis. 2017 Sep;105:33-41. doi: 10.1016/j.nbd.2017.05.007. Epub 2017 May 13.

29.

Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment.

Barrett FS, Workman CI, Sair HI, Savonenko AV, Kraut MA, Sodums DJ, Joo JJ, Nassery N, Marano CM, Munro CA, Brandt J, Zhou Y, Wong DF, Smith GS.

Hum Brain Mapp. 2017 Jul;38(7):3391-3401. doi: 10.1002/hbm.23595. Epub 2017 Apr 5.

30.

Clinical evaluation of brief cognitive assessment measures for patients with severe dementia.

Dixon JS, Saddington DG, Shiles CJ, Sreevalsan KP, Munro CA, Rosenberg PB.

Int Psychogeriatr. 2017 Jul;29(7):1169-1174. doi: 10.1017/S1041610217000151. Epub 2017 Mar 29.

PMID:
28351445
31.

The link between childhood adversity and late-life mental health: evidence for the influence of early-life experiences or illusory correlations?

Vannorsdall TD, Munro CA.

Int Psychogeriatr. 2017 Mar;29(3):357-358. doi: 10.1017/S1041610216002416.

PMID:
28196559
32.

Lactate signalling regulates fungal β-glucan masking and immune evasion.

Ballou ER, Avelar GM, Childers DS, Mackie J, Bain JM, Wagener J, Kastora SL, Panea MD, Hardison SE, Walker LA, Erwig LP, Munro CA, Gow NA, Brown GD, MacCallum DM, Brown AJ.

Nat Microbiol. 2016 Dec 12;2:16238. doi: 10.1038/nmicrobiol.2016.238.

33.

Imaging of Glial Cell Activation and White Matter Integrity in Brains of Active and Recently Retired National Football League Players.

Coughlin JM, Wang Y, Minn I, Bienko N, Ambinder EB, Xu X, Peters ME, Dougherty JW, Vranesic M, Koo SM, Ahn HH, Lee M, Cottrell C, Sair HI, Sawa A, Munro CA, Nowinski CJ, Dannals RF, Lyketsos CG, Kassiou M, Smith G, Caffo B, Mori S, Guilarte TR, Pomper MG.

JAMA Neurol. 2017 Jan 1;74(1):67-74. doi: 10.1001/jamaneurol.2016.3764.

34.

Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening.

Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, Leak RK, Surratt CK.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:22-30. doi: 10.1016/j.pbb.2016.08.007. Epub 2016 Aug 26.

PMID:
27569602
35.

Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping.

Rajendran R, May A, Sherry L, Kean R, Williams C, Jones BL, Burgess KV, Heringa J, Abeln S, Brandt BW, Munro CA, Ramage G.

Sci Rep. 2016 Oct 21;6:35436. doi: 10.1038/srep35436.

36.

Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.

de Veer SJ, Furio L, Swedberg JE, Munro CA, Brattsand M, Clements JA, Hovnanian A, Harris JM.

J Invest Dermatol. 2017 Feb;137(2):430-439. doi: 10.1016/j.jid.2016.09.017. Epub 2016 Sep 30.

37.

Initial feasibility and validity of a prospective memory training program in a substance use treatment population.

Sweeney MM, Rass O, Johnson PS, Strain EC, Berry MS, Vo HT, Fishman MJ, Munro CA, Rebok GW, Mintzer MZ, Johnson MW.

Exp Clin Psychopharmacol. 2016 Oct;24(5):390-399.

38.

Age at menopause and duration of reproductive period in association with dementia and cognitive function: A systematic review and meta-analysis.

Georgakis MK, Kalogirou EI, Diamantaras AA, Daskalopoulou SS, Munro CA, Lyketsos CG, Skalkidou A, Petridou ET.

Psychoneuroendocrinology. 2016 Nov;73:224-243. doi: 10.1016/j.psyneuen.2016.08.003. Epub 2016 Aug 3. Review.

PMID:
27543884
39.

A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients.

Rajendran R, Sherry L, Deshpande A, Johnson EM, Hanson MF, Williams C, Munro CA, Jones BL, Ramage G.

Front Microbiol. 2016 Jun 16;7:915. doi: 10.3389/fmicb.2016.00915. eCollection 2016.

40.

R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.

Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R.

Br J Clin Pharmacol. 2016 Sep;82(3):784-92. doi: 10.1111/bcp.12997. Epub 2016 Jun 20.

41.

Principal components analysis of agitation outcomes in Alzheimer's disease.

Yesavage JA, Taylor JL, Friedman L, Rosenberg PB, Lazzeroni LC, Leoutsakos JS, Kinoshita LM, Perlow MJ, Munro CA, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A; CitAD Research Group.

J Psychiatr Res. 2016 Aug;79:4-7. doi: 10.1016/j.jpsychires.2016.04.004. Epub 2016 Apr 16.

42.

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.

Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP; CitAD Research Group.

Am J Psychiatry. 2016 May 1;173(5):473-80. doi: 10.1176/appi.ajp.2016.15020248. Epub 2016 Apr 1.

PMID:
27032628
43.

Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.

Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano CM, Mintzer J, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade D, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

Am J Psychiatry. 2016 May 1;173(5):465-72. doi: 10.1176/appi.ajp.2015.15050648. Epub 2016 Jan 15.

44.

Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease.

Newell J, Yesavage JA, Taylor JL, Kraemer HC, Munro CA, Friedman L, Rosenberg PB, Madore M, Chao SZ, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A; CitAD Research Group.

J Psychiatr Res. 2016 Mar;74:17-21. doi: 10.1016/j.jpsychires.2015.12.005. Epub 2015 Dec 12.

45.

Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013.

Rajendran R, Sherry L, Nile CJ, Sherriff A, Johnson EM, Hanson MF, Williams C, Munro CA, Jones BJ, Ramage G.

Clin Microbiol Infect. 2016 Jan;22(1):87-93. doi: 10.1016/j.cmi.2015.09.018. Epub 2015 Sep 30.

46.

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.

Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG; CitAD Research Group.

Int Psychogeriatr. 2015 Dec;27(12):2059-67. doi: 10.1017/S1041610215001106. Epub 2015 Aug 25.

47.

Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.

Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG; CitAD Research Group.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1127-33. doi: 10.1016/j.jagp.2015.05.006. Epub 2015 May 19.

48.

Cell Wall Remodeling Enzymes Modulate Fungal Cell Wall Elasticity and Osmotic Stress Resistance.

Ene IV, Walker LA, Schiavone M, Lee KK, Martin-Yken H, Dague E, Gow NA, Munro CA, Brown AJ.

MBio. 2015 Jul 28;6(4):e00986. doi: 10.1128/mBio.00986-15.

49.

Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies.

Walker LA, Lee KK, Munro CA, Gow NA.

Antimicrob Agents Chemother. 2015 Oct;59(10):5932-41. doi: 10.1128/AAC.00862-15. Epub 2015 Jul 13.

50.

Socio-demographic patterns of physical activity and sedentary behaviour in Chile: results from the National Health Survey 2009-2010.

Celis-Morales C, Salas C, Alduhishy A, Sanzana R, Martínez MA, Leiva A, Diaz X, Martínez C, Álvarez C, Leppe J, Munro CA, Siervo M, Willis ND.

J Public Health (Oxf). 2016 Jun;38(2):e98-e105. doi: 10.1093/pubmed/fdv079. Epub 2015 Jun 25.

PMID:
26112281

Supplemental Content

Loading ...
Support Center